Location History:
- Shizuoka, JP (1979 - 1992)
- Ube, JP (1994)
- Mishima, JP (1989 - 1995)
Company Filing History:
17 out of 730 
2 out of 45 
Years Active: 1979-1995
Title: The Innovative Contributions of Katsuichi Shuto
Introduction: Katsuichi Shuto, based in Shizuoka, Japan, is a prominent inventor known for his significant contributions to the field of medicinal chemistry. With a remarkable portfolio comprising 19 patents, Shuto has focused on innovations that address critical health issues, particularly in the treatment of osteoporosis.
Latest Patents: Among his latest inventions, Shuto has developed triphenylmethane derivatives that exhibit bone absorption inhibiting effects. These derivatives hold promising potential as medicaments for treating osteoporosis, marking a notable advancement in pharmaceutical innovation. Another significant invention is a quinoline derivative that demonstrates serotonin-3 receptor antagonizing activity, further showcasing his expertise in creating therapeutic agents.
Career Highlights: Throughout his career, Katsuichi Shuto has been associated with reputable companies in the pharmaceutical sector, notably Kyowa Hakko Kogyo Co., Ltd. and Kyowa Hakko Kogyo Kabushiki Kaisha. His work has advanced both the scientific understanding and practical applications of pharmaceutical compounds, contributing to improved patient outcomes.
Collaborations: Shuto has collaborated with esteemed colleagues, including Shunji Ichikawa and Hiroshi Kase. These partnerships have fostered a rich environment for innovation, enhancing the quality and scope of research and development within their fields.
Conclusion: Katsuichi Shuto's contributions to the field of medicinal chemistry through his innovative patents exemplify the vital role of inventors in healthcare advancement. His work continues to inspire future research and development, paving the way for novel treatments that can significantly impact patients' lives.